NRSNW
NeuroSense Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.01
+4.76%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
713.1%
Return on equity
-1082.2%
Return on assets
797.5%
Return on invested capital
0.00x
Asset turnover
-$3.7M
Cash from operations
$0.01
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025